Brief: Tcr2 Therapeutics Announces Exercise Of Over-Allotment Option
26/02/2019 22:31
Feb 26 (Reuters) - Tcr2 Therapeutics Inc TCRR.O :
* TCR2 THERAPEUTICS ANNOUNCES EXERCISE OF OVER-ALLOTMENT
OPTION
Source text for Eikon: ID:nPnbMfvwta
Further company coverage: TCRR.O
((Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview